Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Wardelmann

Showing results (101-110 of 248) with videos related to

Pageof 25
Sort By:
The American Journal of Surgical Pathology|April 20, 2013
A novel germline KIT mutation (p.L576P) in a family presenting with juvenile onset of multiple gastrointestinal stromal tumors, skin hyperpigmentations, and esophageal stenosisTeresa M Neuhann, Veit Mansmann, Sabine Merkelbach-Bruse, et al.
The Lancet. Oncology|April 7, 2005
Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutationsEva Wardelmann, Nadja Thomas, Sabine Merkelbach-Bruse, et al.
Oncotarget|June 4, 2015
FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitroHelen Künstlinger, Jana Fassunke, Hans-Ulrich Schildhaus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient managementHolger Palmedo, Jan Bucerius, Alexius Joe, et al.
Nature Communications|July 10, 2020
κB-Ras and Ral GTPases regulate acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitisStephanie Beel, Lina Kolloch, Lisa H Apken, et al.
European Journal of Haematology|July 12, 2018
<sup>90</sup> Y-ibritumomab-tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single-center experienceEva U Spukti, Lars Henning Schmidt, Arik Schulze, et al.
International Journal of Cancer|June 10, 2003
Chromosomal region 15q21.1 is a frequent target of allelic imbalance in advanced breast carcinomasKerstin Rhiem, Annette Klein, Miriam Münch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2010
Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapySamer Ezziddin, Martin Opitz, Mared Attassi, et al.
Onkologie|December 18, 2009
Detection of lymphovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastasesMichael Braun, Eva Wardelmann, Manuel Debald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Perioperative Management of Extremity Soft Tissue SarcomasRick L Haas, Alessandro Gronchi, Michiel A J van de Sande, et al.
Pageof 25

Showing results (101-110 of 248) with videos related to

Sort By:
Pageof 25
The American Journal of Surgical Pathology|April 20, 2013
A novel germline KIT mutation (p.L576P) in a family presenting with juvenile onset of multiple gastrointestinal stromal tumors, skin hyperpigmentations, and esophageal stenosisTeresa M Neuhann, Veit Mansmann, Sabine Merkelbach-Bruse, et al.
The Lancet. Oncology|April 7, 2005
Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutationsEva Wardelmann, Nadja Thomas, Sabine Merkelbach-Bruse, et al.
Oncotarget|June 4, 2015
FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitroHelen Künstlinger, Jana Fassunke, Hans-Ulrich Schildhaus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient managementHolger Palmedo, Jan Bucerius, Alexius Joe, et al.
Nature Communications|July 10, 2020
κB-Ras and Ral GTPases regulate acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitisStephanie Beel, Lina Kolloch, Lisa H Apken, et al.
European Journal of Haematology|July 12, 2018
<sup>90</sup> Y-ibritumomab-tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single-center experienceEva U Spukti, Lars Henning Schmidt, Arik Schulze, et al.
International Journal of Cancer|June 10, 2003
Chromosomal region 15q21.1 is a frequent target of allelic imbalance in advanced breast carcinomasKerstin Rhiem, Annette Klein, Miriam Münch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2010
Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapySamer Ezziddin, Martin Opitz, Mared Attassi, et al.
Onkologie|December 18, 2009
Detection of lymphovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastasesMichael Braun, Eva Wardelmann, Manuel Debald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Perioperative Management of Extremity Soft Tissue SarcomasRick L Haas, Alessandro Gronchi, Michiel A J van de Sande, et al.
Pageof 25